evalu
immunogen
inactiv
sar
coronaviru
sarscov
three
group
rabbit
immun
three
time
interv
inactiv
vaccin
adjuv
adjuv
normal
salin
respect
eight
batch
serum
sampl
auricular
vein
day
day
specif
igg
antibodi
titer
neutral
antibodi
titer
detect
indirect
elisa
microcytopath
effect
neutral
test
antibodi
specif
identifi
proteinchip
assay
histopatholog
chang
detect
h
e
stain
result
show
rabbit
experiment
group
immun
inactiv
sarscov
gener
specif
igg
antibodi
neutral
activ
suggest
inactiv
sarscov
could
preserv
antigen
well
elicit
effect
humor
immun
respons
peak
titer
valu
specif
igg
antibodi
neutral
antibodi
reach
respect
experiment
group
obviou
histopatholog
chang
detect
h
e
stain
slide
heart
spleen
kidney
testi
sampl
liver
slight
histopatholog
chang
lung
present
remark
histopatholog
chang
find
import
sarscov
inactiv
vaccin
develop
sever
acut
respiratori
syndrom
sar
novel
viral
epidem
spread
thirti
countri
sever
threaten
worldwid
public
health
clinic
symptom
sar
character
fever
dyspnoea
lymphopenia
rapidli
progress
chang
observ
radiographi
pathogen
affirm
novel
coronaviru
sar
coronaviru
sarscov
virologica
sinica
indirect
enzymelink
immunosorb
assay
elisa
microtit
plate
coat
inactiv
sarscov
dilut
contain
ml
total
viru
protein
serial
serum
dilut
ad
incub
min
plate
wash
pbst
hrpconjug
goatantirabbit
igg
antibodi
dillut
sinoamerican
biotech
ad
incub
min
plate
wash
opd
substrat
ophenylendiamin
sigma
ad
incub
min
reaction
stop
moll
establish
solid
base
effect
control
ultim
erad
diseas
genom
sarscov
map
import
structur
function
protein
determin
mani
featur
regard
nosogenesi
antigen
immuogen
sarscov
still
remain
indistinct
vaccin
play
crucial
role
control
infecti
diseas
previou
experi
human
antivir
vaccin
indic
inactiv
vaccin
much
easier
develop
hold
potenti
investig
sar
inactiv
vaccin
effect
safeti
vaccin
two
import
aspect
effort
focus
investig
immunogen
safeti
inactiv
sarscov
anim
mice
rabbit
pig
hors
paper
report
specif
antibodi
kinet
histopatholog
chang
rabbit
immun
inactiv
sarscov
view
gain
insight
toward
develop
sar
inactiv
vaccin
sarscov
strain
genbank
isol
sampl
onset
sar
patient
guangdong
provinc
china
screen
vaccin
strain
vero
cell
cultiv
routin
mem
medium
contain
bovin
serum
follow
infect
strain
viru
cytopath
effect
cpe
reach
cell
suspens
frozen
thaw
three
time
store
titer
viru
suspens
tcid
ml
determin
micropl
cpe
method
largescal
cultiv
viru
suspens
inactiv
formaldehyd
vv
h
inactiv
effici
precis
identifi
centrifug
g
min
remov
precipit
viru
supernat
tabl
eight
batch
blood
sampl
auricular
vein
day
serum
separ
centrifug
min
store
titer
serum
specif
igg
antibodi
measur
day
first
vaccin
rabbit
sacrifi
autopsi
gain
lung
liver
heart
spleen
kidney
testi
tissu
sampl
organ
fix
neutralbuff
formalin
routin
process
paraffin
embed
serial
section
cut
block
tissu
slice
stain
hemotoxylin
eosin
dye
h
e
detect
photomicrographi
antibodi
titer
eight
batch
serum
sampl
day
day
measur
indirect
elisa
control
group
sera
neg
inactiv
sarscov
antigen
elicit
potent
neutral
antibodi
respons
fig
day
neutral
antibodi
detect
experiment
experiment
group
obviou
histopatholog
chang
detect
h
e
stain
tissu
slide
heart
spleen
kidney
testi
liver
tissu
slight
histopatholog
chang
